Drug Trial Radar · NCT05899842
Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia
Last checked: Nov 20, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
132
Planned (sponsor's estimate)
Start
Jun 1, 2023
Primary completion
Feb 2028
Study completion Feb 2028
Sponsor
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 12, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Per Oral Endoscopic Myotomy (POEM) is a treatment of choice for achalasia with an excellent safety and efficacy profile. There is a high rate of esophagitis related to gastroesophageal reflux following this procedure. There is no recommendation on the prescription of protein pump inhibitors (PPI) after the procedure and no study has studied the benefit of systematic prescription of PPI after POEM for achalasia. The study authors hypothesize that routine PPI prescribing post-POEM for 12 months would reduce the rate of esophageal acid exposure compared to a symptom-based prescribing strategy.
Conditions
- Esophageal Achalasia
Interventions
Protein pump inhibitor therapy systematicallyDrug
Lansoprazole 30mg once per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Presence of pathological acid reflux between groupsTime frame: Month 6
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
AP-HM
Marseille, France · Recruiting
CHU de Montpellier
Montpellier, France · Recruiting
Clinique mutualiste Beausoleil
Montpellier, France · Recruiting
CHU de Nîmes
Nîmes, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.